NPL launches Metrology for Medical Physics Centre, MEMPHYS
MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies.
List view / Grid view
MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies.
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
Researchers have developed a sensing method with the potential to significantly contribute to early detection of cancer and diabetes...
Study shows first applications of DNA origami for nanomedicine...
New injectable delivery system can slowly release drug carriers for months...
Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease...
A team of scientist have developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy...
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
The European Commission has granted marketing authorisation for Mvasi for the treatment of certain types of cancer...
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer...
Researchers have developed a biosensor that can detect diseased exosomes, important indicators of various health conditions...
Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumours...
With access challenges even after successful but costly development programmes, the industry is under pressure to speed up the clinical development process and produce more for less. Adaptive trial designs, more collaborative working and data sharing could provide a solution in the area of cancer immunotherapy, says Jacqueline Karmel, principal…
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...